Company Name: Benitec Biopharma Ltd.
Benitec Biopharma Ltd. is a clinical-stage biotechnology company. The company is engaged in the development of treatments for a variety of conditions using its proprietary ddRNAi gene-silencing technology. The company’s current clinical pipeline includes candidates designed to treat:
- Hepatitis B
- Hepatitis C
- Lung Cancer
- Oculopharyngeal muscular dystrophy
- Wet Age-related Macular Degeneration
Ticker Symbol: BNTC (NASDAQ)
Ticker Symbol: BLT (Australian Securities Exchange)
Company Website: www.benitec.com
Social Media:
Headquarters: Sydney, Australia